最近,通过激酶抑制,对二氨酸异环的抗癌活性取得了进展
Mohamed S Nafie1,2, Sherif Ashraf Fahmy3, Shaima H Kahwash2
1Department of Chemistry, College of Sciences, University of Sharjah Sharjah 27272 United Arab Emirates mohamed.elsayed@sharjah.ac.ae.
RSC advances
|February 20, 2025
概括
二类药物,包括拉,金纳和金诺林,显示出作为新型抗癌药物的前景. 它们独特的化学结构允许量身定制的药物特性,针对关键的癌症生存过程,以改善治疗方法.
科学领域:
- 药用化学 医学化学
- 有机化学 有机化学
- 药理学 药理学是指药理学的学科.
背景情况:
- 类药物 (花素,素,素,素,素) 是含有的异环,具有多种化学结构.
- 这些异环提供可调的药理动力学和药理动力学特性,使它们成为药物开发的有吸引力的支架.
- 现有的二衍生物通过向关键细胞通路,表现出显著的抗癌活性.
研究的目的:
- 审查最近在二衍生物合成方面的进展.
- 为了突出这些化合物作为化疗剂的潜力.
- 整合关于设计策略的信息,以提高抗癌药物开发中的有效性和选择性.
主要方法:
- 对最近的合成方法进行文献综述 对于二衍生物的合成方法.
- 对报告这些化合物的抗癌作用机制的研究分析.
- 评估二衍生物的临床成功和治疗潜力.
主要成果:
- 二衍生物通过抑制拓聚酶,蛋白激酶和受体氨酸激酶,表现出强大的抗癌性质.
- 几种二衍生物在临床上取得了成功,证实了它们的治疗潜力.
- 特定的衍生物,如fthalazine,cinnoline和quinazoline在向癌症治疗中显示出有前途.
结论:
- 二衍生物是新型抗癌药物候选药物的有希望的来源.
- 对设计策略的进一步研究可以优化有效性和选择性,从而改善癌症治疗.
- 这些异环化合物为开发具有减少副作用的更有效化疗药物提供了一条途径.
相关概念视频
Inhibition of Cdk Activity
4.6K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.6K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
215
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
215
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Drugs that Destabilize Microtubules
1.9K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
1.9K
M-Cdk Drives Transition Into Mitosis
5.5K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.5K


